FTC sues makers of diet pills for false claims; ignores Big Pharma's false claims: NewsTarget.com

The U.S. Federal Trade Commission (FTC) announced last week that it had settled with four weight loss pill companies for more than $25 million over complaints the companies had made false, unsubstantiated health claims for their products.

Marketers of four products -- Xenadrine EFX, CortiSlim, TrimSpa and One-A-Day WeightSmart -- settled with the FTC over allegations of false weight loss claims, surrendering millions in money and assets, and consenting to limit future claims.

"You won't find weight loss in a bottle of pills that claims it has the latest scientific breakthrough or miracle ingredient," said Deborah Platt Majoras, chairman of the FTC. "Paying for fad science is a good way to lose cash, not pounds."

Two marketers of Xenadrine EFX are set to pay the FTC from $8 million to $12.8 million to settle complaints of unsubstantiated claims on its product, which was featured in numerous ads in People magazine, TV Guide, Cosmopolitan and Men's Fitness magazine.

The conclusion of this article appears on NewsTarget.com, the independent natural health news source for consumers. This article, along with other uncensored news on important consumer health topics, can be found at:

FTC sues makers of diet pills for false claims; ignores Big Pharma's false claims

http://www.newstarget.com/021403.html

About NewsTarget

Read by over 500,000 unique readers monthly, NewsTarget is a progressive, independent natural health news site that teaches consumers how to improve their health through foods, herbs, exercise and natural therapies. The site also warns consumers about the dangers of processed foods, pharmaceuticals, chemotherapy, environmental toxins and the failure of government regulators like the FDA.